Literature DB >> 7892508

The effect of Clostridium difficile toxin on colonocyte prostanoid activity.

M D Stratton1, B Chandel, Y Deshpande, D L Kaminski, A P Li, A M Vernava, W E Longo.   

Abstract

Antibiotic-associated colitis is caused by Clostridium difficile toxin. However, the pathophysiology of this entity is poorly understood. The aim of this study was to determine the effects of C. difficile toxin on colonocyte cyclooxygenase and phospholipase A2 (PLA2) activity. A transformed colonocyte cell line (Caco-2) was grown to confluency on 6 well plates. The cells were stimulated with graded concentrations of C. difficile toxin. In separate experiments, the cells were pretreated for one hour prior to stimulation with the cyclooxygenase inhibitor, indomethacin, or the glucocorticoid, dexamethasone. The culture media was collected one hour following C. difficile stimulation. Prostaglandin E2 (PGE2), 6-keto prostaglandin F1 alpha (6KPGF), thromboxane B2 (TxB2) and leukotriene B4 (LTB4) levels were determined in the media by an ELISA. Platelet activating factor (PAF) concentration was determined by a RIA. C. difficile toxin stimulated PGE2 and 6KPGF levels in a dose dependent fashion but failed to stimulate TxB2, LTB4 or PAF. Prostanoid production was inhibited by indomethacin dose dependently but was not inhibited by dexamethasone. The presence of indomethacin resulted in production of PAF. Our results show that the effects of C. difficile toxin on colonocytes are mediated by cyclooxygenase activity. The increase in PAF formation associated with indomethacin administration suggests that the prostanoids modulate PLA2 activity and inhibit PAF formation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7892508     DOI: 10.1016/0090-6980(94)90003-5

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  5 in total

1.  Clostridium difficile toxin B differentially affects GPCR-stimulated Ca2+ responses in macrophages: independent roles for Rho and PLA2.

Authors:  Robert A Rebres; Christina Moon; Dianne Decamp; Keng-Mean Lin; Iain D Fraser; Stephen B Milne; Tamara I A Roach; H Alex Brown; William E Seaman
Journal:  J Leukoc Biol       Date:  2010-03-03       Impact factor: 4.962

2.  Cyclooxygenase inhibition attenuates cholecystokinin-induced gastroprotection.

Authors:  D W Mercer; G S Smith; T A Miller
Journal:  Dig Dis Sci       Date:  1998-03       Impact factor: 3.199

3.  The role of cyclooxygenase-1 and cyclooxygenase-2 in lipopolysaccharide and interleukin-1 stimulated enterocyte prostanoid formation.

Authors:  W E Longo; L J Damore; J E Mazuski; G S Smith; N Panesar; D L Kaminski
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

4.  The effect of trinitrobenzene sulfonic acid on gut-derived smooth muscle cell arachidonic acid metabolism: role of endogenous prostanoids.

Authors:  W E Longo; G S Smith; Y Deshpande; C Reickenberg; D L Kaminski
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

5.  The effect of an interleukin receptor antagonist (IL-1ra) on colonocyte eicosanoid release.

Authors:  G S Smith; C Rieckenberg; W E Longo; D L Kaminski; J E Mazuski; Y Deshpande; T A Miller
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.